Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

79.61
BATS BZX Real-Time Price
As of 9:35am ET
 -0.69 / -0.86%
Today’s Change
69.90
Today|||52-Week Range
98.97
-7.47%
Year-to-Date
Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higher
Aug 24 / MotleyFool.com - Paid Partner Content
Novartis: First-Class Pharmaceuticals
Aug 19 / GuruFocus News - Paid Partner Content
Merck Offers Value and Steady Dividend Growth
Aug 24 / GuruFocus News - Paid Partner Content
Better Buy: Amgen Inc. vs. Biogen
Aug 17 / MotleyFool.com - Paid Partner Content
Novartis Licenses Anti-PCSK9 Antibody to Cyon Therapeutics
Aug 24 / Zacks.com - Paid Partner Content
Allergan to Buy ForSight VISION5, Boost Glaucoma Pipeline
Aug 15 / Zacks.com - Paid Partner Content
3 Reasons Medivation Is the Juiciest Target in Biotech
Aug 21 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close80.30
Today’s open79.86
Day’s range79.61 - 79.86
Volume7,335
Average volume (3 months)1,727,377
Market cap$186.6B
Dividend yield3.41%
Data as of 9:35am ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)+77.51%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.15%
Revenue growth (last year)-4.75%
P/E ratio29.0
Price/Sales4.25
Price/Book2.47

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc0.000.00%
MRKMerck+0.07+0.11%
PFEPfizer-0.12-0.34%
GSKGlaxoSmithKline-0.04-0.09%
Data as of 9:35am ET, 08/25/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$1.20
Annual revenue (last year)$49.4B
Annual profit (last year)$17.8B
Net profit margin14.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Joseph Jimenez
Chief Financial Officer
Harry Kirsch
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts

Partner Offers

Search for Jobs